Sie sind hier: Startseite Aktuelles Archiv Vorträge und … Archiv




Time: 10 - 12 am
Jon Michael Gran

University of Oslo

Estimating causal effects in non-Markov multi-state models


Dr. Katharina Schultebraucks
NYU School of Medicine, Department of Psychiatry

Identifying early risk factors for PTSD - a machine learning approach

9.30 a.m.

Dr. James Hanley
McGill University Montreal
Match or model? sample or entire base? Statistical strategies in etio-, dia-, and pro-gnostic research


Mark Baillie
Novartis, Basel
How do we make better graphs? Effective visual communication for the quantitative scientist

Prof. Dr. Riccardo De Bin
University of Oslo, Department of Mathematics
Detection of influential points as a byproduct of resampling‐based variable selection procedures

Dr. Tibor Schuster
Mc Gill.CA, Department of Family Medicine
Non-collapsibility: the root of all evil when estimating and interpreting marginal hazard ratios.

Georg Heinze,
Medical University of Vienna
Prediction and explanation in studies with rare events: problems and solutions.


Georg Heinze, Christine Wallisch
Medical University of Vienna, Center for Medical Statistics, Informatics and Intelligent Systems
Variable selection – a review and recommendations for the practicing statistician.


Prof. Micha Mandel,
Department of Statistics, The Hebrew University of Jerusalem
The illness–death model under cross-sectional sampling.


Vivian Viallon,
Nutritional Methodology and Biostatistics Group (NMB) International Agency for Research on Cancer World Health Organization
Using structural causal models to identify biases in standard epidemiological analyses.


Prof. Dr. Reinhard Meister
Beuth Hochschule für Technik Berlin

23.10.2017 Prof. Dr. Heiko Becher
Universitätsklinikum Hamburg-Eppendorf
Methods to estimate the number of lung cancer cases caused by passive smoking in Germany
15.00 Uhr

Antritts- / Abschiedsvorlesung im Hörsaal der Anatomie, Albertstraße 17

Prof. Dr. Martin Schumacher
11 Dinge, die man bei der Analyse biomedizinischer Daten unbedingt vermeiden sollte


Prof. Dr. Harald Binder
Künstliche Intelligenz, Deep Learning und die Rolle der Biometrie


26.06.2017 Itai Dattner
Department of Statistics, University of Haifa, Israel

Statistical learning of age-dependent dynamics from incidence data

04.04.2017 Walter Zingg
University of Geneva

Assessing the burden of healthcare-associated infection by prevalence surveys

06.02.2017 Dr. Alison Abraham, PhD
The Johns Hopkins University School of Medicine

Clinical care practice and the cohort study: moving from observation to intervention

05.12.2016 Dr. Ewelina Kotwa
  On robust statistics, chemometrics and the importance to know what we are doing!
28.11.2016 10.30 - 11.30 Uhr
Dr. Steffen Unkel,
Institut für Med. Statistik, Universitätsmedizin Göttingen

Statistical Methods for Outbreak Detection

  11.30 - 12.30 Uhr
Dr. Benjamin Blümel,
Institut für Mikrobiologie und Hygiene, Universitätsklinikum Freiburg
Microbiological Hospital Data from the Medical Center Freiburg
21.11.2016 Prof. Dr. André Scherag
Universitätsklinikum Jena
  Methodological challenges of hospital-wide nosocomial infection monitoring within the ALERTS study - an example of our ongoing work within the "Center for Sepsis Control and Care" (CSCC)
14.11.2016 Yessica Fermin
Abt. Statistik, Uni Dortmund
  Nonparametric Bayesian analysis of dynamic protein-networks in heterogeneous cell populations
Dienstag, 26.07.2016 Prof. Dr. Meinhard Kieser
Medizinische Biometrie und Informatik, Universitätsklinikum Heidelberg
  Phase-II-Studien in der Onkologie – Ist Simons optimales Design das Optimum?
18.07.2016 Rafael Mikolajczyk
Helmholtz Zentrum für Infektionsforschung, Braunschweig
  Insights from network modelling of the spread of pathogens between hospitals

Workshop: Pseudovalues und Supermodels

Alina Nicolaie (RIVM, Netherlands)
Dynamic pseudo-observations: A robust approach to dynamic prediction in competing risks

Daniela Zöller (Uni Mainz)
Using pseudo-values and simultaneous variable selection to extract a core set of variables for dynamic prediction models

Maja von Cube (Uni Freiburg)
Dynamic prediction approach to analyse the population-attributable fraction of hospital-acquired infections

Harriet Sommer (Uni Freiburg)
The cure-death model and its application to observational studies

27.06.2016 Alex Aiken
  Matched parallel cohort study designs to evaluate the burden of nosocomial infections
20.06.2016 Prof. Dr. Casey Rebholz
Johns Hopkins University Baltimore
  Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease in the Atherosclerosis Risk in Communities (ARIC) Study: An Application of Structural Equation Modeling
19.04.2016 Dr. Christine Gräfin zu Eulenburg, Universität Hamburg
  Selection bias in on-treatment analyses: results from the Serve-HF study
21.03.2016 Madlen Gebauer
Institute of Statistics, Ulm University
  Nested case-control designs in a subsequent event setting
01.02.2016 Dr. Riccardo De Bin
Medizinische Informationsverarbeitung, Biometrie und Epidemiologie - Schwerpunkt Biometrie, Ludwig-Maximilians-Universität München
  On the use of different strategies to combine clinical and high-throughput omics predictors in a prediction model
06.07.2015 Prof. Dr. Tim Friede
Institut für Medizinische Statistik, Universität Göttingen
  Exploratory and confirmatory subgroup analyses in clinical trials
27.04.2015 Prof. Dr. Markus Scholz
Institut für Medizinische Informatik, Statistik und Epidemiologie, Universität Leipzig
  On the molecular-genetic research program of the LIFE study
30.03.2015 Bella Vakulenko-Lagun
Department of Statistics, The Hebrew University of Jerusalem
  What could be done with prevalent data in the illness-death model?
02.03.2015 Guiliana Cortese
Department of Statistical Sciences, Padua University
  Prediction Models for Competing Risks with time-dependent covariates
19.01.2015 Christian Hennig, University College London
  Measurement of quality in cluster analysis
15.12.2014 Dr. Aris Perperoglou, Essex

Approaches in modelling long term survival: models, time functions and some data

22.09.2014 Nathalie Stoer

Reuse of controls from nested case-control designs

23.07.2014 Prof. Dr. med. Antje Timmer, Fakultät VI, Department für Versorgungsforschung, Carl von Ossietzky Universität Oldenburg

„Alte Schläuche, neue Kühe“ - Versorgungsforschung und klinische Epidemiologie.

28.04.2014 Ralf Bender, Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)

Analyse unerwünschter Ereignisse im Rahmen der Nutzenbewertung von Arzneimitteln.

13.01.2014 Simon Wood, Mathematical Science, University of Bath, UK

Additive models beyond exponential family: smooth Cox proportional hazards etc.

17.06.2013 Prof. Dr. Rolf Holle, Helmholtz Zentrum München

Besonderheiten ökonomischer RCTs am Beispiel der KORINNA-Studie

10.06.2013 Dr. Isabella Zwiener, Universität Mainz

Building prognostic gene signatures with RNA-Seq data

08.04.2013 Virginie Rondeau
  Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units
18.02.2013 Philipp Doebler
  Diagnostic meta‐analysis with the R‐package mada
28.01.2013 Ulrike Krahn
  Evaluating the validity of network meta-analyses: locating inconsistency and visualizing the flow of evidence
03.07.2012 Prof. Dr. Joachim Röhmel
  Systematische Übersichtsarbeiten zur „ethischen“ Literatur. Konzeptionelle und praktische Herausforderungen
  Prof. Dr. Werner Vach
  Über die Sinnhaftigkeit der gesetztlichen Vorgaben zur Quantifizierung und Kategorisierung des Zusatznutzens bei Arzneimitteln
11.06.2012 Daniel Strech
  Systematische Übersichtsarbeiten zur „ethischen“ Literatur. Konzeptionelle und praktische Herausforderungen
16.04.2012 Prof. Hans van Houwelingen
  Dynamic prediction of survival with clinical and genomic data
13.02.2012 Anna Nachtnebel  
  Evaluation von Diagnostika aus der HTA- Perspektive
09.01.2012 Laura Antolini  
  Performance of binary markers for censored failure time outcome: nonparametric approach based on proportions
07.11.2011 Prof. Dr. Ulrich Mansmann  
  Counter-factual responder analysis in parallel group RCTs using covariates
04.07.2011 Nicholas Graves  
  Economics and cost-effectiveness modelling for reducing healthcare acquired infection
21.02.2011 Georg Heinze  
  Nonlinear interactions, confounding, and missing values: an interesting case study
25.10.2010 Dr. Heike Spaderna  
  Spielen psychosoziale und verhaltensbezogene Patientenmerkmale eine Rolle für die Prognose während der Wartezeit auf eine Herztransplantation? – Anwendung eines competing risks-Modell.
15.03.2010 Dr. Oliver Teuffel  
  Ambulante Therapiestrategien zur Behandlung von Fieber und Neutropenie: Eine Kosten-Nutzwert Analyse.
11.01.2010 Bernd Fitzenberger  
  MCMC estimation of the heterogeneous effects of treatment incidence and treatment duration.
05.10.2009 Raymond J. Carroll  
  Robust Powerful Methods for Understanding Gene-Gene and Gene-Environment Interactions
24.08.2009 Cornelis Biesheuvel, Stockholm  
  Overdiagnosis of invasive breast cancer associated with mammograhpy screening
25.05.2009 Holger Höfling  
  Estimation of Sparse Binary Markov Networks
27.04.2009 Prof. Hans C. van Houwelingen, Leiden University Medical Center  
  Frailties in multi-state models: Are they identifiable? Do we need them?
20.04.2009 Adrian Barnett  
  Estimating the effect of Methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit using a longitudinal model
02.04.2009 Mei-Jie Zhang
  Modeling Right Censored and Left Truncated Competing Risks Failure Time Data Using Inverse Weighting Technique
09.03.2009 Jean-Francois Timsit  
  Estimation of the Excess mortality of nosocomial infections and iatrogenic events: Potential Pitfalls
09.02.2009 Theo Stijnen  
  Meta-analysis of diagnostic test accuracy data
19.01.2009 Ananthram Murthy  
  Principles of health economic evaluation: Cost-effectiveness of universal rapid screening of MRSA.
23.06.2008 Dr. Oliver Kuss, Institut für Medizinische Epidemiologie, Biometrie und Informatik, Martin-Luther-Universität Halle-Wittenberg  
  Gibt es einen Unterschied zwischen randomisierten und nicht-randomisierten Studien in ähnlichen Patientegruppen? - Evidenz aus einer „Meta-Propensity Score-Analyse“ in der Herzchirurgie
09.06.2008 Raphael Porcher, Département de Biostatistique et Informatique Médicale, Hôpital Saint Louis Paris  
  Adaptive and flexible designs
07.05.2008 David Siegmund, Stanford University
  Mapping Quantitative Traits
28.04.2008 Prof. Reinhard Meister, Berlin  
  The competing risk approach adapted to left truncation allows reliable estimation of abortion risk from observational studies.
25.02.2008 Antje Jahn-Eimermacher  
  Statistical analysis of recurrent failure time data: Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children.
18.02.2008 Stijn Vansteelandt, Department of Applied Mathematics and Computer Science, Ghent University, Belgien  
  Marginal Structural Models for the effect of ICU-acquired nosocomial pneumonia on survival.
28.01.2008 Anne-Laure Boulesteix, Sylvia Lawry Centre for Multiple Sclerosis Research, München  
  Hybrid classifiers based on clinical predictors and high-dimensional microarray data using PLS and random forests
21.01.2008 Laurence Colin, Novartis Basel
  A Multivariate Survival Analysis of Recurrent Surgical Interventions for Retinal Detachment: the SPR Study  
17.12.2007 Melanie Weck, Heidelberg  
  Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition
19.11.2007 Marta Fiocco, Leiden University, Netherlands  
  A multi-state model for bone marrow transplantation using the mstate package
18.06.2007 Marcel Wolber
Basel Institute for Clinical Epidemiology
University Hospital Basel, Switzerland
  Two-stage Randomization Designs in Drug Development
23.04.2007 Stéphane Hugonnet
University of Geneva Hospitals, Switzerland,
Infection control program
  Nosocomial infection: a look into risk factors and methodological issues
01.12.2006    Dr. Laura Antolini
Universita of Milano-Bicocca, Dipartimento di medicina clinica prevenzione e biotecnologie sanitarie

Explained Variation and Discrimination Measures for Censored Survival Data
07.08.2006    Dr. Martin Bootsma
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London

Estimating transmission parameters for infectious diseases in small hospital units
31.07.2006    Dr. Donna Pauler Ankerst
Research Scientist Institute for Medical Informatics, Biometry and Epidemiology; University of Munich

Joint statistical models for longitudinal prostate-specific antigen (PSA) and time of prostate recurrence: do they improve prediction of recurrence for new patients?
10.07.2006    Dr. Guido Knapp
Fachbereich Statistik, Universität Dortmund

Neuere statistische Methoden in der Meta-Analyse
26.06.2006    Prof. Per Kragh Andersen
Regression analysis for multistate models based on a pseudo-value approach, with applications to bone marrow transplantation studies.
27.03.2006    Dr. Christine Lonjou, INSERM Toulouse
Disease mapping and linkage disequilibrium based approach
11.04.2005    Aurelien Latouche
Regression Modelling of Competing Risks
14.02.2005    Dr. James Carpenter
Values in Clinical Trials:Handle with Sensitivity!
12.07.2004    Prof. Dr. Dieter Hölzel
Bevölkerungsbezogene Krebsregister: eine Infrastruktur für die Versorgung und die klinische Forschung mit Analysen zur Metastasierung beim Mammakarzino
12.03.2004    Dr. Til Stürmer
Controlling Confounding Using Propensity Scores: Increasing Use, Persisting Questions, and New Venues
12.03.2004    Professor Gerda Claeskens
Frequentist model averaging and focussed model selection
27.10.2003    Elke Klein
Validierung von SAS-Programmen zur Auswertung klinischer Studien
16.06.2003    Hein Putter
Reduced rank proportional hazards models for competing risks
16.06.2003    PD Dr. Tom Smith
Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2
27.01.2003    Dr. Ulrich Schach
Modellierung von MRI-Parametern in der Krankheitsanalyse von Multipler Skleros

SS1986 - WS2003/04